Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Migraine

Free Subscription 16.09.2019 1 Cephalalgia 5 Headache 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Cephalalgia

1. DIENER HC, Goadsby PJ, Ashina M, Al-Karagholi MA, et al
   Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial.
   Cephalalgia. 2019 Sep 15:333102419876920. doi: 10.1177/0333102419876920.
   PubMed     Text format     Abstract available
   
   

   
   Headache

2. MASTERS-ISRAILOV A, Robbins MS
   OnabotulinumtoxinA Wear-off Phenomenon in the Treatment of Chronic Migraine.
   Headache. 2019 Sep 16. doi: 10.1111/head.13638.
   PubMed     Text format     Abstract available
   
   
3. HAMMOND NG, Orr SL, Colman I
   Early Life Stress in Adolescent Migraine and the Mediational Influence of Symptoms of Depression and Anxiety in a Canadian Cohort.
   Headache. 2019 Sep 16. doi: 10.1111/head.13644.
   PubMed     Text format     Abstract available
   
   
4. BARBANTI P, Egeo G, Mitsikostas DD
   Trigeminal-Targeted Treatments in Migraine: Is 60% the Magic Number?
   Headache. 2019 Sep 11. doi: 10.1111/head.13635.
   PubMed     Text format     Abstract available
   
   
5. VANDERPLUYM JH, Hamilton K, Hindiyeh NA, Robbins MS, et al
   Online Migraine Education and Support for Patients: Perspectives from the American Headache Society Emerging Leaders Program.
   Headache. 2019 Sep 11. doi: 10.1111/head.13649.
   PubMed     Text format    
   
   
6. CHING J, Tinsley A, Rothrock J
   Prognosis Following Discontinuation of OnabotulinumA Therapy in "Super-responding" Chronic Migraine Patients.
   Headache. 2019 Sep 9. doi: 10.1111/head.13630.
   PubMed     Text format     Abstract available
   
   

   
   PLoS One

7. YEO JH, Choi EJ, Lee J
   Inhibition of gap junctional intercellular communication by an anti-migraine agent, flunarizine.
   PLoS One. 2019;14:e0222326.
   PubMed     Text format     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: